List of Excipients in API clindamycin phosphate usp, 1%
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing clindamycin phosphate usp, 1%
Detailed excipient profiles for clindamycin phosphate usp, 1%
Excipient focus: ALLANTOIN
clindamycin phosphate usp, 1% drug variants containing ALLANTOIN
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | clindamycin phosphate usp, 1% | 50090-5958 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate usp, 1% drug variants not containing ALLANTOIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOMER HOMOPOLYMER TYPE B
clindamycin phosphate usp, 1% drug variants containing CARBOMER HOMOPOLYMER TYPE B
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | clindamycin phosphate usp, 1% | 50090-5958 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate usp, 1% drug variants not containing CARBOMER HOMOPOLYMER TYPE B
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
clindamycin phosphate usp, 1% drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | clindamycin phosphate usp, 1% | 50090-5958 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate usp, 1% drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
clindamycin phosphate usp, 1% drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | clindamycin phosphate usp, 1% | 50090-5958 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate usp, 1% drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
clindamycin phosphate usp, 1% drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | clindamycin phosphate usp, 1% | 50090-5958 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate usp, 1% drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
clindamycin phosphate usp, 1% drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | clindamycin phosphate usp, 1% | 50090-5958 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate usp, 1% drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
clindamycin phosphate usp, 1% drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | clindamycin phosphate usp, 1% | 50090-5958 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate usp, 1% drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch